IP Verse

Intervet International B.v. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Intervet International B.v.

Patent Number:
EP3148576
Title:
Vaccine Composition Against Streptococcus Suis Infection
Applicant:
CEVA SANTÉ ANIMALE S.A.
Opposition Date:
Jul 27, 2021
Patent Number:
EP3344289
Title:
Pestivirus Vaccines For Congenital Tremors
Applicant:
BOEHRINGER INGELHEIM VETMEDICA GMBH
Opposition Date:
Oct 28, 2020
Patent Number:
EP2873733
Title:
Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M. Hyopneumoniae Strains, And Use Thereof
Applicant:
HIPRA SCIENTIFIC, S.L.U.
Opposition Date:
Mar 26, 2020
Patent Number:
EP2785374
Title:
Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Sep 30, 2019
Patent Number:
EP2998315
Title:
Newcastle Disease Virus Vectored Avian Vaccines
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Jul 10, 2019
Patent Number:
EP2992897
Title:
Immunogenic Compositions Comprising Lawsonia Intercellularis
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Apr 2, 2019
Patent Number:
EP1968630
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Oct 23, 2018
Patent Number:
EP2957284
Title:
Animal Pest Control Method
Applicant:
E. I. DU PONT DE NEMOURS AND COMPANY
Opposition Date:
Oct 17, 2018

Latest patents of Intervet International B.v. opposed by its competitors

Patent:
EP2688587
Grant Date:
Aug 16, 2023
Title:
Salmonid Alphavirus Vaccine
Oppositions:
1
Patent:
EP3049108
Grant Date:
Jun 21, 2023
Title:
Dry Formulations Of Vaccines That Are Room Temperature Stable
Oppositions:
1
Patent:
EP2833867
Grant Date:
May 10, 2023
Title:
Solid Oral Pharmaceutical Compositions For Isoxazoline Compounds
Oppositions:
2
Patent:
EP2545777
Grant Date:
Jan 18, 2023
Title:
Isoxazoline Compositions And Their Use As Antiparasitics
Oppositions:
2
Patent:
EP3883603
Grant Date:
Dec 21, 2022
Title:
A Vaccine For Protection Against Streptococcus Suis
Oppositions:
1
Patent:
EP3471766
Grant Date:
Dec 14, 2022
Title:
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus Antigens
Oppositions:
1
Patent:
EP2658541
Grant Date:
Jan 26, 2022
Title:
Topical Localized Isoxazoline Formulation Comprising Glycofurol
Oppositions:
1
Patent:
EP2658542
Grant Date:
Jan 26, 2022
Title:
Topical Localized Isoxazoline Formulation
Oppositions:
1
Patent:
EP2922526
Grant Date:
Oct 27, 2021
Title:
Manufacturing Of Semi-Plastic Pharmaceutical Dosage Units
Oppositions:
1
Patent:
EP3473101
Grant Date:
May 12, 2021
Title:
Isoxazoline Compositions And Their Use As Antiparasitics For Felines
Oppositions:
2

Competitors of Intervet International B.v.

BOEHRINGER INGELHEIM VETMEDICA GMBH

CEVA SANTE ANIMALE

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

Want to track Intervet International B.v.?

Feel free to send us a message here and we will get back to you